Phase III Trials Products (Inflammation and Immunology)
FY, 2018
Filed Trials Products (Solid Tumors)
FY, 2018
Phase I Trials Products (Cellular Therapies)
FY, 2016
Metrics | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|
Phase III Trials Products (Inflammation and Immunology) | 5 | 2 | 4 |
Filed Trials Products (Solid Tumors) | 4 | 4 | 4 |
Phase I Trials Products (Cellular Therapies) | 2 | ||
Phase II Trials Products (Cellular Therapies) | 2 | ||
Filed Trials Products (Lymphoma) | 4 | 6 | 6 |
Phase I Trials Products (Lymphoma) | 5 | 5 | 5 |
Phase III Trials Products (Lymphoma) | 4 | 3 | 3 |
Filed Trials Products (Acute Myeloid Leukemia) | 2 | 3 | 3 |
Phase I Trials Products (Acute Myeloid Leukemia) | 3 | 2 | 3 |
Phase III Trials Products (Acute Myeloid Leukemia) | 1 | 1 | 1 |
Phase II Trials Products (Solid Tumors) | 3 | 3 | |
Phase I Trials Products (Solid Tumors) | 4 | 5 | 3 |
Phase III Trials Products (Solid Tumors) | 1 | 1 | 4 |
Phase III Trials Products (Beta Thalassemia) | 1 | 1 | 1 |
Filed Trials Products (Myelodysplastic Syndromes) | 2 | 2 | 2 |
Phase I Trials Products (Myelodysplastic Syndromes) | 1 | 1 | |
Phase II Trials Products (Myelodysplastic Syndromes) | 2 | 2 | 1 |
Phase III Trials Products (Myelodysplastic Syndromes) | 2 | 2 | 2 |
Filed Trials Products (Multiple Myeloma) | 4 | 5 | 5 |
Phase I Trials Products (Multiple Myeloma) | 6 | 4 | 4 |
Phase I Trials Products (Chronic Lymphocytic Leukemia) | 2 | 1 | |
Active Clinical Studies | 52 | ||
Phase II Trials Products (Acute Myeloid Leukemia) | 1 | 1 | |
Filed Trials Products (Inflammation and Immunology) | 2 | 2 | 2 |
Phase I Trials Products (Inflammation and Immunology) | 3 | 3 | 3 |
Phase II Trials Products (Inflammation and Immunology) | 6 | 6 | 3 |
Phase II Trials Products (Multiple Myeloma) | 1 | 1 | |
Phase I/II Trials Products (Lymphoma) | 1 | 1 | |
Phase I/II Trials Products (Chronic Lymphocytic Leukemia) | 1 | 1 | |
Phase II Trials Products (Myelofibrosis) | 1 | 1 | |
Phase I/II Trials Products (Multiple Myeloma) | 1 |